医薬品添加剤市場：タイプ、製剤、機能、エンドユーザー別-2025-2030年の世界予測

医薬品添加剤市場は、2023年に86億2,000万米ドルと評価され、2024年には92億2,000万米ドルに達すると予測され、CAGR 7.62％で成長し、2030年には144億2,000万米ドルに達すると予測されています。

医薬品賦形剤は、医薬品の有効成分（API）と一緒に配合される不活性物質で、医薬品の安定性、バイオアベイラビリティ、デリバリーを促進する上で重要な役割を果たします。様々な医薬品製剤に不可欠で、結合、コーティング、可溶化、保存などの機能性を提供します。賦形剤は経口剤、外用剤、非経口剤、吸入剤など様々な用途で利用されており、主な最終用途分野は病院、診療所、研究機関などです。医薬品添加剤市場の成長は、主に製薬セクターの拡大、医薬品認可の増加、ドラッグデリバリーシステムの大幅な進歩によってもたらされます。さらに、経口薬や技術的に進歩した多機能賦形剤に対する需要の増加が市場拡大の道を開いています。しかし、市場は厳しい規制ガイドラインや新規賦形剤の開拓に伴う高コストといった課題に直面しており、これが成長の妨げになる可能性があります。また、賦形剤と医薬品の相互作用による潜在的なリスクや、製剤の一貫性に影響を与える賦形剤特性のばらつきといった限界もあります。

最新のビジネスチャンスとしては、バイオ医薬品への注目の高まりと個別化医療の導入の拡大が挙げられます。環境に対する意識の高まりから、天然で持続可能な賦形剤を求める動きが絶えず、技術革新の絶好の場となっています。ペプチドやタンパク質製剤の賦形剤開発において、バイオテクノロジー企業との協力関係を模索することは、成長をさらに促進する可能性があります。共加工賦形剤や多機能賦形剤の調査も競争優位性をもたらす可能性があります。市場は非常にダイナミックであり、急速な技術進歩と次世代賦形剤の強力なパイプラインが特徴です。企業は戦略的に、革新的な賦形剤のタイプや製剤への研究開発投資に注力し、共同研究を活用して能力を高め、最新の医薬品製剤の多様な需要に応えるべきです。賦形剤のニーズが満たされていないニッチ市場を特定し、それに合わせてソリューションを調整することで、市場での重要な地位を確保することができます。

市場力学：急速に進化する医薬品添加剤市場における主要な市場インサイトの解明

医薬品添加剤市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界のがんおよびその他の慢性・感染症罹患率の上昇
  • ジェネリック医薬品や希少疾病用医薬品への大きな需要と相まっての医薬品業界の成長
  • 多機能賦形剤の製造の重視
• 市場抑制要因
  • 高度な賦形剤の製造に伴う高コスト
• 市場機会
  • 賦形剤のナノテクノロジー技術の進歩
  • 多くの特性を持つ賦形剤の継続的研究開発（バイオベース）
• 市場の課題
  • 規制の厳格化と賦形剤の適合性に関する問題の増加

ポーターのファイブフォース：医薬品添加剤市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：医薬品添加剤市場における外部からの影響の把握

外部マクロ環境要因は、医薬品添加剤市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析医薬品添加剤市場における競合情勢の把握

医薬品添加剤市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス医薬品添加剤市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、医薬品添加剤市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨医薬品添加剤市場における成功への道筋を描く

医薬品添加剤市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大の可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中でがんやその他の慢性疾患、感染症の発生率が上昇
    • 医薬品業界の成長とジェネリック医薬品および希少疾病用医薬品の大きな需要
    • 多機能賦形剤の製造に重点を置く
  • 抑制要因
    • 高度な賦形剤の製造に伴う高コスト
  • 機会
    • 賦形剤のナノテクノロジーにおける技術的進歩
    • さまざまな特性を持つ賦形剤の継続的な研究開発（バイオベース）
  • 課題
    • 規制の厳格化と添加剤の適合性に関する問題の増加
• 市場セグメンテーション分析
  • タイプ：有機添加剤の潜在的需要と利用
  • 製剤：ドラッグデリバリーの利便性から経口製剤の需要が高い
  • 機能：コーティング剤は薬剤を物理的、化学的に保護します
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 医薬品添加剤市場：タイプ別

• 無機
  • 炭酸カルシウム
  • リン酸カルシウム
  • 硫酸カルシウム
  • 岩塩
  • 金属酸化物
• オーガニック
  • 炭水化物
    • セルロース
    • スターチ
    • 糖類
  • 油脂化学品
    • 脂肪アルコール
    • グリセリン
    • ミネラルステアレート
  • 石油化学製品
    • アクリルポリマー
    • グリコール
    • ブチレングリコール
    • ジエチレングリコール
    • エチレングリコール
    • ヘキシレングリコール
    • マクロゴール
    • マイクログリコール
    • プロピレングリコール
    • 鉱物炭化水素
    • ポビドン
  • タンパク質

第7章 医薬品添加剤市場処方別

• 経口製剤
  • ハードゼラチンカプセル
  • 液体製剤
  • ソフトゼラチンカプセル
  • タブレット
• 非経口製剤
• 局所用製剤

第8章 医薬品添加剤市場：機能別

• バインダー
• コーティング剤
• 着色剤
• 崩壊剤
• 乳化剤
• 充填剤と希釈剤
• 香料・甘味料
• 潤滑剤と滑剤
• 防腐剤
• 懸濁剤および粘性剤

第9章 医薬品添加剤市場：エンドユーザー別

• バイオ医薬品企業
• 契約製造組織
• 製薬会社
• 調査室

第10章 南北アメリカの医薬品添加剤市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の医薬品添加剤市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの医薬品添加剤市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • エボニックの新しいスプレー乾燥施設は、経口添加剤の世界の供給と持続可能性を強化します
  • ロケット社がIFFファーマソリューションズを戦略的に買収し、ドラッグデリバリーソリューションおよび賦形剤市場における世界の影響力を強化
  • 旭化成、低亜硝酸塩のセオラスMCC賦形剤と生産拡大で医薬品の安全性を向上
  • ロケット社が湿気対策の新技術を発表
  • クラリアント、バルセロナのCPHIでAPIの安定性と溶解性を向上させる新しい添加剤シリーズを発表
  • BASFとIFFがバーチャル製薬アシスタントプラットフォームZoomLabで提携
  • ルブリゾール、受賞歴のあるアピソレックス賦形剤をウェルトン・ファーマにライセンス供与し、新たながん治療薬を開発
  • イングレディオン、高付加価値医薬品原料への戦略的投資拡大を発表
  • DFE Pharma、Lactohale 400の発売により吸入ポートフォリオを拡大
  • エボニックは米国政府と提携し、米国にmRNAベースの治療薬用の新しい脂質生産施設を建設するために2億2,000万米ドルを投資します。
  • ルーブリゾールがアピソレックス技術を発表
  • ユニバーソリューションズ、アッシュランドとの新たな販売契約を通じて医薬品ポートフォリオを拡大
  • アゼリス、ロケットとの提携拡大でインドにおける医薬品事業を強化
  • ロケット社、クレスト・セルロース社の完全買収により植物由来賦形剤ポートフォリオの世界展開を拡大
• 戦略分析と提言

企業一覧

• ABITEC Corporation
• Actylis
• Archer Daniels Midland Company
• ARMOR PROTEINES S.A.S.
• Asahi Kasei Corporation
• Ashland Inc.
• BASF SE
• BIOGRUND GmbH
• Chemische Fabrik Budenheim KG
• Clariant AG
• Colorcon Inc.
• Corel Pharma Chem Private Limited
• Croda International Plc
• Darling Ingredients, Inc.
• DFE Pharma GmbH & Co KG
• DuPont de Nemours, Inc.
• Evonik Industries AG
• Fuji Chemical Industries Co., Ltd.
• GATTEFOSSE SAS
• Innophos Holdings, Inc.
• International Flavors & Fragrances Inc.
• JRS PHARMA GmbH+Co. KG
• Kerry Group P.L.C.
• Lipoid GmbH
• Lubrizol Corporation
• L'AIR LIQUIDE S.A.
• Mallinckrodt plc
• MEGGLE GmbH & Co. KG
• Merck KGaA
• Nagase & Co., Ltd.
• Nipon Soda Co., Ltd.
• NOF Corporation
• Omya International AG
• Peter Greven GmbH & Co. KG
• R.T. Vanderbilt Holding Company, Inc.
• Roquette Freres S.A.
• Shin-Etsu Chemical Co., Ltd.
• Solvay S.A.
• SPI Pharma, Inc.
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. PHARMACEUTICAL EXCIPIENT MARKET RESEARCH PROCESS
• FIGURE 2. PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. PHARMACEUTICAL EXCIPIENT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. PHARMACEUTICAL EXCIPIENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PHARMACEUTICAL EXCIPIENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PHARMACEUTICAL EXCIPIENT MARKET DYNAMICS
• TABLE 7. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM CARBONATE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM PHOSPHATE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM SULFATE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HALITES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY METAL OXIDES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CELLULOSE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUGARS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FATTY ALCOHOLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCERIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL STEARATES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ACRYLIC POLYMERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY BUTYLENE GLYCOL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DIETHYLENE GLYCOL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ETHYLENE GLYCOL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HEXYLENE GLYCOL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MACROGOL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MICROGLYCOL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PROPYLENE GLYCOL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL HYDROCARBONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY POVIDONES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HARD GELATIN CAPSULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 46. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SOFT GELATIN CAPSULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 47. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 48. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 49. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PARENTERAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 50. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TOPICAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 51. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 52. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY BINDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 53. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COATING AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 54. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COLORANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 55. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISINTEGRANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 56. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY EMULSIFYING AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 57. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FILLERS & DILUENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 58. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FLAVORING AGENTS & SWEETENERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 59. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 60. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PRESERVATIVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 61. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 62. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 64. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 65. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 66. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 67. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 69. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 70. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 71. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 72. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 73. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 74. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 75. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 76. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 77. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 79. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 81. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 82. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 83. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 84. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 85. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 86. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 87. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 88. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 89. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 92. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 93. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 94. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 95. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 96. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 97. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 98. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 99. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 100. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 103. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 104. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 105. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 106. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 107. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 108. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 109. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 110. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 111. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 114. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 115. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 116. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 117. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 118. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 119. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 120. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 121. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 122. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 125. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 126. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 127. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 128. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 129. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 130. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 131. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 132. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 133. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 135. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 137. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 138. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 139. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 140. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 141. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 142. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 143. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 144. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 145. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 147. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 148. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 149. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 150. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 151. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 152. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 153. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 154. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 155. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 156. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 157. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 158. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 159. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 160. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 161. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 162. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 163. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 164. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 165. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 166. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 167. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 168. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 169. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 170. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 171. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 172. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 173. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 174. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 175. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 176. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 177. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 178. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 179. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 180. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 181. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 182. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 183. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 184. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 185. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 186. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 187. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 188. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 189. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 190. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 192. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 193. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 194. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 195. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 196. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 197. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 198. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 199. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 200. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 201. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 202. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 203. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 204. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 205. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 206. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 207. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 208. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 209. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 210. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 211. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 212. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 213. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 214. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 215. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 216. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 217. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 218. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 219. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 220. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 221. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 222. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 223. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 224. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 225. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 226. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 227. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 228. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 229. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 230. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 231. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 232. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 233. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 234. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 235. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 236. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 237. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 238. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 239. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 244. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 245. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 246. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 247. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 248. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 249. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 250. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 251. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 252. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 253. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 254. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 255. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 256. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 257. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 258. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 259. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 260. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 261. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 262. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 263. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 264. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 265. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 266. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 267. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 268. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 269. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 270. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 271. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 272. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 273. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 274. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 275. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 276. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 277. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 278. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 279. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 280. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 281. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 282. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 283. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 284. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 285. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 286. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 287. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 288. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 289. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 290. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 291. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 292. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 293. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 294. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 295. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 296. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 297. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 298. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 299. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 300. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 301. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 302. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 303. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 304. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 305. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 306. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 307. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 308. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 309. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 310. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 311. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 312. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 313. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 314. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 315. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 316. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 317. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 318. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 319. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 320. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 321. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 322. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 323. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 324. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 325. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 326. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 327. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 328. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 329. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 330. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 331. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 332. FRANCE PHARMACEUTICAL EX

The Pharmaceutical Excipient Market was valued at USD 8.62 billion in 2023, expected to reach USD 9.22 billion in 2024, and is projected to grow at a CAGR of 7.62%, to USD 14.42 billion by 2030.

Pharmaceutical excipients are inactive substances formulated alongside the active pharmaceutical ingredient (API) of a medication, serving critical roles in promoting stability, bioavailability, and delivery of the drug. They are essential in various drug formulations, offering functionalities such as binding, coating, solubilizing, and preserving. Excipients are utilized across several applications, including oral, topical, parenteral, and inhalation preparations, with key end-use sectors comprising hospitals, clinics, and research institutions. The growth of the pharmaceutical excipient market is primarily driven by the expanding pharmaceutical sector, increased drug approvals, and significant advancements in drug delivery systems. Additionally, the rise in demand for oral medications and technologically advanced multifunctional excipients is opening avenues for market expansion. However, the market faces challenges, such as stringent regulatory guidelines and high costs associated with the development of new excipients, which can hinder growth. Limitations include potential risks of excipient-drug interactions and variability in excipient characteristics, impacting formulation consistency.

Among the latest opportunities are the rising focus on biopharmaceuticals and the growing implementation of personalized medicine, which necessitates novel excipient development to cater to unique delivery and stability needs. There's a continuous push towards natural and sustainable excipients due to growing environmental awareness, providing an excellent area for innovation. Exploring collaborations with biotech firms for excipient development in peptide and protein formulations can further drive growth. Research into co-processed and multifunctional excipients can also yield competitive advantages. The market is highly dynamic, characterized by rapid technological advancements and a robust pipeline of next-generation excipients. Businesses should strategically focus on R&D investments in innovative excipient types and formulations, leveraging collaborations to enhance capabilities and meet the diverse demands of modern drug formulations. Identifying niche markets with unmet excipient needs and tailoring solutions accordingly can secure a significant market position.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Excipient Market

The Pharmaceutical Excipient Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidence of cancer and other chronic and infectious diseases worldwide
  • Growth of the pharmaceuticals industry coupled with significant demand for generics & orphan drugs
  • Significant emphasis on the production of multifunctional excipients
• Market Restraints
  • High cost associated with the production of advanced excipient
• Market Opportunities
  • Technological advancements in nanotechnology for excipients
  • Ongoing research and development of excipients with numerous properties (Biobased)
• Market Challenges
  • Increasing regulatory stringency and issues regarding the compatibility of excipients

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Excipient Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Excipient Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Excipient Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Excipient Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Excipient Market

A detailed market share analysis in the Pharmaceutical Excipient Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Excipient Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Excipient Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Excipient Market

A strategic analysis of the Pharmaceutical Excipient Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Excipient Market, highlighting leading vendors and their innovative profiles. These include ABITEC Corporation, Actylis, Archer Daniels Midland Company, ARMOR PROTEINES S.A.S., Asahi Kasei Corporation, Ashland Inc., BASF SE, BIOGRUND GmbH, Chemische Fabrik Budenheim KG, Clariant AG, Colorcon Inc., Corel Pharma Chem Private Limited, Croda International Plc, Darling Ingredients, Inc., DFE Pharma GmbH & Co KG, DuPont de Nemours, Inc., Evonik Industries AG, Fuji Chemical Industries Co., Ltd., GATTEFOSSE SAS, Innophos Holdings, Inc., International Flavors & Fragrances Inc., JRS PHARMA GmbH + Co. KG, Kerry Group P.L.C., Lipoid GmbH, Lubrizol Corporation, L'AIR LIQUIDE S.A., Mallinckrodt plc, MEGGLE GmbH & Co. KG, Merck KGaA, Nagase & Co., Ltd., Nipon Soda Co., Ltd., NOF Corporation, Omya International AG, Peter Greven GmbH & Co. KG, R.T. Vanderbilt Holding Company, Inc., Roquette Freres S.A., Shin-Etsu Chemical Co., Ltd., Solvay S.A., SPI Pharma, Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Excipient Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Inorganic and Organic. The Inorganic is further studied across Calcium Carbonate, Calcium Phosphate, Calcium Sulfate, Halites, and Metal Oxides. The Organic is further studied across Carbohydrates, Oleochemicals, Petrochemicals, and Proteins. The Carbohydrates is further studied across Cellulose, Starch, and Sugars. The Oleochemicals is further studied across Fatty Alcohols, Glycerin, and Mineral Stearates. The Petrochemicals is further studied across Acrylic Polymers, Glycols, Mineral Hydrocarbons, and Povidones. The Glycols is further studied across Butylene Glycol, Diethylene Glycol, Ethylene Glycol, Hexylene Glycol, Macrogol, Microglycol, and Propylene Glycol.
• Based on Formulation, market is studied across Oral Formulations, Parenteral Formulations, and Topical Formulations. The Oral Formulations is further studied across Hard Gelatin Capsules, Liquid Formulations, Soft Gelatin Capsules, and Tablets.
• Based on Function, market is studied across Binders, Coating Agents, Colorants, Disintegrants, Emulsifying Agents, Fillers & Diluents, Flavoring Agents & Sweeteners, Lubricants & Glidants, Preservatives, and Suspending & Viscosity Agents.
• Based on End-User, market is studied across Biopharmaceutical Companies, Contract Manufacturing Organizations, Pharmaceutical Companies, and Research Laboratories.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidence of cancer and other chronic and infectious diseases worldwide
    • 5.1.1.2. Growth of the pharmaceuticals industry coupled with significant demand for generics & orphan drugs
    • 5.1.1.3. Significant emphasis on the production of multifunctional excipients
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with the production of advanced excipient
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in nanotechnology for excipients
    • 5.1.3.2. Ongoing research and development of excipients with numerous properties (Biobased)
  • 5.1.4. Challenges
    • 5.1.4.1. Increasing regulatory stringency and issues regarding the compatibility of excipients
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Potential demand and utilization of organic excipients
  • 5.2.2. Formulation: Significant demand for oral formulations owing to its convenient drug delivery
  • 5.2.3. Function: Coating agents provide physical and chemical protection for the drug
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Pharmaceutical Excipient Market, by Type

• 6.1. Introduction
• 6.2. Inorganic
  • 6.2.1. Calcium Carbonate
  • 6.2.2. Calcium Phosphate
  • 6.2.3. Calcium Sulfate
  • 6.2.4. Halites
  • 6.2.5. Metal Oxides
• 6.3. Organic
  • 6.3.1. Carbohydrates
    • 6.3.1.1. Cellulose
    • 6.3.1.2. Starch
    • 6.3.1.3. Sugars
  • 6.3.2. Oleochemicals
    • 6.3.2.1. Fatty Alcohols
    • 6.3.2.2. Glycerin
    • 6.3.2.3. Mineral Stearates
  • 6.3.3. Petrochemicals
    • 6.3.3.1. Acrylic Polymers
    • 6.3.3.2. Glycols
    • 6.3.3.2.1. Butylene Glycol
    • 6.3.3.2.2. Diethylene Glycol
    • 6.3.3.2.3. Ethylene Glycol
    • 6.3.3.2.4. Hexylene Glycol
    • 6.3.3.2.5. Macrogol
    • 6.3.3.2.6. Microglycol
    • 6.3.3.2.7. Propylene Glycol
    • 6.3.3.3. Mineral Hydrocarbons
    • 6.3.3.4. Povidones
  • 6.3.4. Proteins

7. Pharmaceutical Excipient Market, by Formulation

• 7.1. Introduction
• 7.2. Oral Formulations
  • 7.2.1. Hard Gelatin Capsules
  • 7.2.2. Liquid Formulations
  • 7.2.3. Soft Gelatin Capsules
  • 7.2.4. Tablets
• 7.3. Parenteral Formulations
• 7.4. Topical Formulations

8. Pharmaceutical Excipient Market, by Function

• 8.1. Introduction
• 8.2. Binders
• 8.3. Coating Agents
• 8.4. Colorants
• 8.5. Disintegrants
• 8.6. Emulsifying Agents
• 8.7. Fillers & Diluents
• 8.8. Flavoring Agents & Sweeteners
• 8.9. Lubricants & Glidants
• 8.10. Preservatives
• 8.11. Suspending & Viscosity Agents

9. Pharmaceutical Excipient Market, by End-User

• 9.1. Introduction
• 9.2. Biopharmaceutical Companies
• 9.3. Contract Manufacturing Organizations
• 9.4. Pharmaceutical Companies
• 9.5. Research Laboratories

10. Americas Pharmaceutical Excipient Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Pharmaceutical Excipient Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Pharmaceutical Excipient Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Evonik's new spray drying facility enhances global supply and sustainability of oral excipients
  • 13.3.2. Roquette's strategic acquisition of IFF Pharma Solutions to bolster global influence in drug delivery solutions and excipients market
  • 13.3.3. Asahi Kasei enhances pharmaceutical safety with low-nitrite Ceolus MCC excipient and expanded production
  • 13.3.4. Roquette Introduces New Advancement in Moisture Protection
  • 13.3.5. Clariant Launches New Range Of Excipients To Improve Stability And Solubility of Apis at CPHI Barcelona
  • 13.3.6. BASF, IFF Partner on Virtual Pharma Assistant Platform ZoomLab
  • 13.3.7. Lubrizol Licenses Award-Winning Apisolex Excipient to Welton Pharma to Develop a Novel Cancer Therapeutic
  • 13.3.8. Ingredion Announces Strategic Investments Expanding Into High-Value Pharmaceutical Ingredients
  • 13.3.9. DFE Pharma Expands its Inhalation Portfolio with the Launch of Lactohale 400
  • 13.3.10. Evonik invests USD 220 million in partnership with the U.S. Government to build a new lipid production facility for mRNA-based therapies in the U.S.
  • 13.3.11. Lubrizol Launches Apisolex Technology
  • 13.3.12. Univar Solutions Expands Pharmaceutical Products Portfolio Through New Distribution Agreement with Ashland
  • 13.3.13. Azelis Strengthens Its Pharmaceutical Presence in India By Expanding its Partnership With Roquette
  • 13.3.14. Roquette Expands Global Reach of Plant-Based Excipients Portfolio with Complete Acquisition of Crest Cellulose
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. ABITEC Corporation
• 2. Actylis
• 3. Archer Daniels Midland Company
• 4. ARMOR PROTEINES S.A.S.
• 5. Asahi Kasei Corporation
• 6. Ashland Inc.
• 7. BASF SE
• 8. BIOGRUND GmbH
• 9. Chemische Fabrik Budenheim KG
• 10. Clariant AG
• 11. Colorcon Inc.
• 12. Corel Pharma Chem Private Limited
• 13. Croda International Plc
• 14. Darling Ingredients, Inc.
• 15. DFE Pharma GmbH & Co KG
• 16. DuPont de Nemours, Inc.
• 17. Evonik Industries AG
• 18. Fuji Chemical Industries Co., Ltd.
• 19. GATTEFOSSE SAS
• 20. Innophos Holdings, Inc.
• 21. International Flavors & Fragrances Inc.
• 22. JRS PHARMA GmbH + Co. KG
• 23. Kerry Group P.L.C.
• 24. Lipoid GmbH
• 25. Lubrizol Corporation
• 26. L'AIR LIQUIDE S.A.
• 27. Mallinckrodt plc
• 28. MEGGLE GmbH & Co. KG
• 29. Merck KGaA
• 30. Nagase & Co., Ltd.
• 31. Nipon Soda Co., Ltd.
• 32. NOF Corporation
• 33. Omya International AG
• 34. Peter Greven GmbH & Co. KG
• 35. R.T. Vanderbilt Holding Company, Inc.
• 36. Roquette Freres S.A.
• 37. Shin-Etsu Chemical Co., Ltd.
• 38. Solvay S.A.
• 39. SPI Pharma, Inc.
• 40. Thermo Fisher Scientific Inc.